The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the treatment of multiple chronic ...

The US Food and Drug Administration (FDA) has designated Celltrion’s Yuflyma (adalimumab-aaty) as an interchangeable biosimilar to AbbVie’s Humira (adalimumab). The decision allows Yuflyma to be ...

Leading pharmacy benefit managers are shifting away from lucrative rebates on biologic drugs and toward lower-cost biosimilar ...

US FDA designates Celltrion’s Yuflyma as an interchangeable biosimilar to Humira: Incheon, South Korea Wednesday, April 16, 2025, 16:00 Hrs [IST] Celltrion, Inc. announced that ...

The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the ...

But, Roche Holdings AG took the chance with a head-to-head study it financed pitting its rheumatoid arthritis treatment Actemra against the market-leader Humira, Abbott Laboratories' blockbuster.

Coherus BioSciences, Inc.’s CHRS share price has dipped by 5.19%, which has investors questioning if this is right time to ...

AbbVie claimed FDA approval for its JAK inhibitor Rinvoq (upadacitinib) for rheumatoid arthritis on Friday, setting its price just a little below that of its antibody blockbuster Humira.

The kit contains prefilled Humira pens. When prescribed to treat rheumatoid arthritis (RA), the typical dosage of Humira is 40 mg every other week. Your doctor might increase your Humira dosage ...

For treating rheumatoid arthritis (RA) in adults, the recommended Humira dosage is 40 mg every other week. In some cases, your doctor may increase your dosage of Humira for RA. Specifically, ...

For example, your doctor may advise you to take ibuprofen in combination with Humira to treat rheumatoid arthritis or psoriatic arthritis. If you have questions about NSAIDs or other pain ...